Sol-Gel Technologies Ltd. Analytics - Traffic, Statistics and Competitor Tracking


Sol-Gel Technologies Ltd. Website Screenshot

http://www.sol-gel.com

Sol-Gel Technologies Ltd. Company Intro

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, which has completed Phase II clinical trials for the treatment of acne vulgaris; Epsolay that has completed Phase II clinical trials for the treatment of papulopustular rosacea; SGT-210, a epidermal growth factor receptor inhibitor, which is in development for the treatment of palmoplantar keratoderma and non-melanoma skin cancer; and tapinarof and roflumilast to treat psoriasis and other dermatological indications. It is also involved in the development of generic topical dermatological drug products. Sol-Gel Technologies Ltd. has collaboration with Perrigo; and Douglas Pharmaceuticals for the development and commercialization of a generic product candidate. The company was founded in 1997 and is headquartered in Ness Ziona, Israel.

Industry

Healthcare

Sol-Gel Technologies Ltd. Headquaters

7 Golda Meir Street
Ness Ziona,7403650
Israel


Sol-Gel Technologies Ltd. Share price

07 May 2021 02:41 GMT

$9.55

0.02 (0.21 %)


Sol-Gel Technologies Ltd. Market cap

$221.728 M


WMC RANKING

2021

Sol-Gel Technologies Ltd. # 170

Biotechnology

Latest Sol-Gel Technologies Ltd. News



WMC Market Score


WMC Market to Revenue Score


Sol-Gel Technologies Ltd. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Sol-Gel Technologies Ltd. USD $10,734 $41,154 $-29,404 $2,217M 170
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $531,210B 1
Vertex Pharmaceuticals Incorporated USD $6,205,683 $2,599,993 $2,711,647 $556,170B 2
Alexion Pharmaceuticals, Inc. USD $6,069,900 $2,656,500 $603,400 $375,420B 3
Incyte Corporation USD $2,229,409 $1,622,822 $446,906 $180,980B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Sol-Gel Technologies Ltd. Social Followers vs Top 4 Industry Competitors



Sol-Gel Technologies Ltd. Post vs Top 4 Industry Competitors




Sol-Gel Technologies Ltd. Digital Footprint By Size vs Top 4 Industry Competitors



Sol-Gel Technologies Ltd. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Sol-Gel Technologies Ltd. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Sol-Gel Technologies Ltd. 0.12 0 0 0 0 0 0.04
Regeneron Pharmaceuticals, Inc. 100 23.94 3.18 100 0 0 48.88
Vertex Pharmaceuticals Incorporated 67.14 35.00 1.01 86 0 0 46.84
Alexion Pharmaceuticals, Inc. 65.67 100 100 60 0 0 100
Incyte Corporation 24.12 4.94 0.07 2 0 0 2.86

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries